Sanofi launches effervescent vaccine technology; Global veterinary group sets guidelines for treating epilepsy; FDA drafts labeling guidance;

> Sanofi's ($SNY) animal health division, Merial, announced it has launched Avinew NeO, a vaccine for the prevention of Newcastle disease in poultry that comes in an effervescent tablet rather than a traditional vial and syringe. Release

> A group of veterinarians and scientists have formed the International Veterinary Epilepsy Task Force and established the first standardized guidelines for the research, diagnosis and treatment of the disease in dogs and cats. Article

> The FDA has released draft guidance that describes issues the agency takes into account when deciding whether to take action against new animal drug distributors who issue products with labels that differ from the approved labeling language. Release

> Dechra Pharmaceuticals announced that its revenues grew 10% year-over-year in fiscal 2015 to to £203.5 million ($314 million) at constant currency rates, driven largely by sales of its companion animal products. Article

> Animart, a veterinary service provider for the dairy industry in Wisconsin, acquired Animal Medic, a supplier of dairy health products in the Northeast. Article

> Merck ($MRK) Animal Health has awarded three scholarships to veterinary students who have committed to working in food animal production. More

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…